Search
Biogen to Acquire RayThera for Up to $1 Billion
1 week ago /
Read about 0 minute
Author：小编
Biogen plans to acquire biotechnology company RayThera for up to $1 billion, including upfront payments and clinical and regulatory milestone payments. This move aims to expand Biogen's pipeline of investigational products in the field of immunology. RayThera focuses on the development of small molecule therapies in immunology.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
